Search

Your search keyword '"Ye, Xin"' showing total 2 results
2 results on '"Ye, Xin"'

1. Safety and efficacy of microwave ablation for lung cancer adjacent to the interlobar fissure.

Author

Wang, Nan, Xu, Jingwen, Wang, Gang, Xue, Guoliang, Li, Zhichao, Cao, Pikun, Hu, Yanting, Cai, Hongchao, Wei, Zhigang, and Ye, Xin

Subjects
PNEUMONIA, PLEURAL effusions, LUNG tumors, MICROWAVES, RETROSPECTIVE studies, SURGICAL complications, TREATMENT effectiveness, SURVIVAL analysis (Biometry), PROGRESSION-free survival, ABLATION techniques, PATIENT safety, PNEUMOTHORAX
Abstract

Background: This retrospective study aimed to assess the safety and efficacy of microwave ablation for lung tumors adjacent to the interlobar fissures. Methods: From May 2020 to April 2021, 59 patients with 66 lung tumors (mean diameter, 16.9 ± 7.7 mm; range, 6–30 mm) adjacent to the interlobar fissures who underwent microwave ablation at our institution were identified and included in this study. Based on the relationship between the tumor and the interlobar fissure, tumors can be categorized into close to the fissure, causing the fissure, and involving the fissure. The complete ablation rate, local progression‐free survival, complications, and associated factors were analyzed. Results: All 66 histologically proven tumors were treated using computed tomography‐guided microwave ablation. The complete ablation rate was 95.5%. Local progression‐free survival at 3, 6, 9, and 12 months were 89.4%, 83.3%, 74.2%, and 63.6%, respectively. The complications included pneumothorax (34.8%), pleural effusion (24.2%), cavity (18.2%), and pulmonary infection (7.6%). There were statistical differences in the incidence of pneumothorax, cavity, and delayed complications between the groups with and without antenna punctures through the fissure. Conclusions: Microwave ablation is a safe and effective treatment for lung tumor adjacent to the interlobar fissure. Antenna puncturing though the interlobar fissure may be a potential risk factor for pneumothorax, cavity, and delayed complications. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

2. Microwave ablation for lung cancer patients with a single lung: Clinical evaluation of 11 cases

Author

Yang, Xia, Ye, Xin, Zhang, Licheng, Geng, Dianzhong, Du, Zhenli, Yu, Guohua, Ren, Haipeng, Wang, Jiao, Huang, Guanghui, Wei, Zhigang, Ni, Yang, Li, Wenhong, and Han, Xiaoying

Subjects
Male, Hemoptysis, Lung Neoplasms, Pneumothorax, Hemorrhage, Original Articles, Middle Aged, NSCLC, Disease-Free Survival, Pleural Effusion, Microwave ablation, single lung, Catheter Ablation, Humans, Original Article, Female, Neoplasm Recurrence, Local, Microwaves, Pneumonectomy, Tomography, X-Ray Computed, Lung, Aged, Retrospective Studies
Abstract

Background The study was conducted to retrospectively evaluate the safety and effectiveness of computed tomography (CT)‐guided percutaneous microwave ablation (MWA) for peripheral non‐small cell lung cancer (NSCLC) in 11 patients with a single lung after pneumonectomy. Methods From May 2011 to March 2015, 11 single‐lung patients (8 men and 3 women; mean age 60.3 years, range 46–71) with peripheral NSCLC underwent 12 sessions of MWA. Eleven tumors measuring 13–52 mm (mean 30.2 mm) were treated. Follow‐up was performed via CT scan at 1, 3, 6, 12, 18, and 24 months after the procedure and annually thereafter. Clinical outcomes were evaluated and complications after MWA were summarized. Results At a median follow‐up period of 20 months (range 6–38), four patients showed evidence of local recurrence at a rate of 36.4% (4/11). Median overall survival was 20 months. The overall survival rates at one, two, and three years after MWA were 88.7%, 63.6%, and 42.3%, respectively. Complications after MWA included pneumothorax (33.3%), hemoptysis (33.3%), intrapulmonary bleeding (25%), pleural effusion (16.7%), and pulmonary infection (8.3%). None of the patients died during the procedure or in the 30 days after MWA. Conclusion CT‐guided percutaneous MWA is safe and effective for the treatment of peripheral NSCLC in patients with a single lung after prior pneumonectomy.

Published
2018

Catalog

Books, media, physical & digital resources
See catalog results